Evidence map›Paper›PMID 41922875›Full record

ArticleNature structural & molecular biology2026

MitoPerturb-Seq identifies gene-specific single-cell responses to mitochondrial DNA depletion and heteroplasmy.

Stephen P Burr, Kathryn Auckland, Angelos Glynos, Abhilesh Dhawanjewar, Cameron Ryall, Wei Wei, Antony Hynes-Allen, Malwina Prater, Matylda Sczaniecka-Clift, Julien Prudent and 2 more

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephen P Burr *MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-8865-126X
Kathryn Auckland *MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-7583-2886
Angelos GlynosMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
Abhilesh DhawanjewarMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-7827-1255
Cameron RyallMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-1039-6155
Wei WeiMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-2945-3543
Antony Hynes-AllenMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
Malwina PraterMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-8202-5345
Matylda Sczaniecka-CliftMRC Laboratory of Molecular Biology, University of Cambridge, Cambridge, UK.
Julien PrudentMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0003-3821-6088
Patrick F ChinneryMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. pfc25@cam.ac.uk.ORCID http://orcid.org/0000-0002-7065-6617
Jelle van den AmeeleMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK. jv361@cam.ac.uk.ORCID http://orcid.org/0000-0002-2744-0810

Funding

Wellcome Trust
6 · The paper itself

Abstract

Mitochondria contain their own genome, mitochondrial DNA (mtDNA), which is under strict control by the cell nucleus. mtDNA occurs in many copies per cell and mutations often only affect a proportion of them, giving rise to heteroplasmy. mtDNA copy number and heteroplasmy level together shape the tissue-specific impact of mtDNA mutations, eventually giving rise to both rare mitochondrial and common neurodegenerative diseases. Here, we use MitoPerturb-Seq for CRISPR-Cas9-based, high-throughput single-cell interrogation of the nuclear genes and pathways that sense and control mtDNA copy number and heteroplasmy. We screened a panel of mtDNA maintenance genes in mouse cells with a heteroplasmic mtDNA mt-Ta mutation. This revealed both common and perturbation-specific aspects of the integrated stress response to mtDNA depletion caused by Tfam, Opa1 and Polg knockout. These responses are only partially mediated by ATF4 and cause cell-cycle stage-independent slowing of cell proliferation. MitoPerturb-Seq, thus, provides experimental insight into disease-relevant mitochondrial-nuclear interactions and may inform development of therapies targeting cell-type- and tissue-specific vulnerabilities to mitochondrial dysfunction.

Indexed as

DNA, MitochondrialHeteroplasmyMitochondriaSingle-Cell AnalysisActivating Transcription Factor 4AnimalsCell ProliferationCRISPR-Cas SystemsDNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA Polymerase gammaGTP PhosphohydrolasesHigh Mobility Group ProteinsMiceMitochondrial ProteinsMutationActivating Transcription Factor 4DNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA, MitochondrialDNA Polymerase gammaGTP PhosphohydrolasesHigh Mobility Group ProteinsMitochondrial ProteinsOpa1 protein, mousePolg protein, mouseTfam protein, mouseTranscription Factors

Identifiers

PMID41922875
PMCPMC13095666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.